LeafNLP Demos
Back to explore

Report #2881828

Received Jan 14, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
16 yrs
State
UT
Recovered
Unknown
Vaccinated
Nov 1, 2025
Onset
Nov 1, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNPMENINGOCOCCAL CONJUGATE (PENMENVY)GLAXOSMITHKLINE BIOLOGICALSUNK55723—

Symptoms (1)

Product preparation issue

Symptom narrative

Penmenvy liquid portion only administration; Penmenvy liquid portion only administration; This non-serious case was reported by a other health professional and described the occurrence of inappropriate dose of vaccine administered in a female patient who received Men ABCWY NVS (Penmenvy) (batch number 55723, expiry date 08-OCT-2026) for prophylaxis. In NOV-2025, the patient received Penmenvy. In NOV-2025, an unknown time after receiving Penmenvy, the patient experienced inappropriate dose of vaccine administered (Verbatim: Penmenvy liquid portion only administration) and inappropriate preparation of medication (Verbatim: Penmenvy liquid portion only administration). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-DEC-2025 Penmenvy not give, only prefilled syringe of MenB.